|Articles|August 13, 2020
- Applied Clinical Trials-08-01-2020
- Volume 29
- Issue 7/8
Applied Clinical Trials, August 2020 Issue (PDF)
Click here for a link to open the Applied Clinical Trials August 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Integration of Biomarker Validation in Oncology Trialsover 5 years ago
Immunomodulators and Cancer Researchover 5 years ago
COVID Exposes the Cracks in Trial Problemsover 5 years ago
The RACE for Children Act Takes Effect This Monthover 5 years ago
Designing Cell Therapies to Target Solid Tumorsover 5 years ago
The Importance of Biomarker Managementover 5 years ago
Clinical Trials Can Duck the European GMO Problemover 5 years ago
Clinical Trial At-Home Service Providersover 5 years ago
News Notesover 5 years ago
Initial Design Considerations for Immuno-Oncology TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
Worldwide Clinical Trials to Acquire Catalyst Clinical Research, Expanding Oncology and FSP Capabilities
4
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
5